1888 PressRelease Home	Sign In	Register	About Us	Sitemap

1888 Press Release | Curasan Ag Press Releases

Curasan.de - Curasan Ag Company News Section

Curasan Ag Information

Andrea Weidner

curasan AG LindigstraÃŸe 4 63801 Kleinostheim Germany
Phone: 49 (0)6027 40 900-51
URL: http://www.curasan.de

curasan AG is publicly traded (ISIN: DE 000 549 453 8) and is one of the leading firms in the field of bone and tissue regeneration. In addition to the synthetic CerasorbÂ® bone regeneration material, the company has developed a future-oriented product pipeline. The goal during the next few years is to bring further medical products to market readiness and to market them via well-positioned contractual partners in various submarkets.

Curasan Ag Press Release -

Curasan.de

18 NOV	curasan AG signs a research agreement with Ben-Gurion University
	curasan AG, which is listed on the General Standard of the German Stock Exchange, has signed a research and development agreement with the Ben-Gurion University of the Negev (BGU), Israel.

17 OCT	curasan AG received licence for ATR®
	curasan AG has been received CE certification and, therefore, marketing authorization for the ATR® (Advanced Tissue Regeneration) product.

13 OCT	curasan AG to invest approximately 1 million euros in future growth – product pipeline well filled
	curasan AG is to invest in its future growth by implementing a technological investment programme amounting to approximately 1 million euros, despite the current crisis in the financial markets.

03 JUL	Curavisc® after knee arthroscopy examined in clinical trial: significant reduction in pain and earlier mobility
	A Curavisc® trial was presented at the 58th Annual Conference of the North German Association of Orthopaedic Surgeons – proof of the safer, more effective use of a hyaluronic acid preparation from curasan AG – Curavisc® is recommended for routine clinical use.

09 JUN	Cerasorb® M provides ideal substrate for embryonic stem cells
	Outstanding suitability of Cerasorb® M for tissue engineering – Studies confirm positive results regarding the colonisation of Cerasorb® M with various types of cells – curasan AG intends to provide support to embryonic stem cell research with the highly suitable substrate Cerasorb®.

19 May	Cerasorb® M used successfully during acetabular cup replacement
	curasan AG presented innovative medical products from the Cerasorb® umbrella brand at the 57th annual congress of the Association of South-German Orthopaedic Surgeons (Vereinigung Süddeutscher Orthopäden e. V.) – Report on experiences with the use of Cerasorb® M during revision operations to correct acetabular cup loosening in the hip joint.